-
Mylan marks 25th anniversary of EpiPen's approval by giving it away for free
BASKING RIDGE, N.J. — Mylan Specialty announced Thursday the introduction of a "$0 Co-Pay Offer" on a product used to treat severe allergic reactions.
The drug maker is offering a co-pay card to patients with or without insurance for the EpiPen in recognition of the 25th anniversary of its approval by the Food and Drug Administration. The co-pay card is available online at EpiPen.com, and the offer will expire on Dec. 31.
-
J&J launches diabetes education site for European healthcare professionals
BEERSE, Belgium — Johnson & Johnson subsidiary Janssen has launched an interactive educational website about diabetes for European healthcare professionals.
Dubbed the Janssen Diabetes Forum, the website is designed to educate users about the latest developments in the management of Type 2 diabetes. The website was launched Tuesday in Beerse, Belgium.